Pricing and Access—From IRA to Innovation: 2024 Trends

No Comments

A look at how legislation—and the wider quest for more transparency on drug costs and reimbursement—may impact manufacturer product launch and pricing strategies in the years ahead.

Leave a Reply

Your email address will not be published. Required fields are marked *